Health Care: Drugs


$4.88 n/a | n/a%
06/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.88
52 Week High 11.19
52 Week Low 2.73
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) 1.59
Share Related Items
Mkt Cap (Mil) 78.28
Shares Out (Mil) 16.04
Float (Mil) 2.65
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.50
Current Ratio 3.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 5.52
Price/Cash Flow -3.00
Per Share Data
Earnings -1.71
Sales 0.00
Book Value 0.88
Cash Flow -1.62
Business Summary
GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.
General Information
175 Toyota Plaza
7th Floor
Memphis, TN 38103
Industry : Drugs
Sector: Health Care
Employees: 25
CEO: Mr. Marc S. Hanover
Short Interest
Current Month (Mil) 0.48
Previous Month (Mil) 0.08
Short Interest Ratio (Days) 0.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -137.70
Return on Investments -183.90
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with GTXI

Latest GTXI Headlines from TheStreet

More Financial News for GTXI

Press Releases for GTXI

See All Press Releases

Partner Headlines for GTXI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter